Influenza Drug Platform Could Yield Candidates for Multiple Pathogens - Genetic Engineering & Biotechnology News

Influenza Drug Platform Could Yield Candidates for Multiple Pathogens  Genetic Engineering & Biotechnology News

Sialylated antibody fragment drugs could help combat potential flu pandemic by targeting viral proteins that are key to infection of host cells.